The store will not work correctly when cookies are disabled.
5-chloro-3-phenyl-6,7-dihydropyrrolo[3,4-g]indol-8(1H)-one
ID: ALA5290575
Max Phase: Preclinical
Molecular Formula: C16H11ClN2O
Molecular Weight: 282.73
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1NCc2c(Cl)cc3c(-c4ccccc4)c[nH]c3c21
Standard InChI: InChI=1S/C16H11ClN2O/c17-13-6-10-11(9-4-2-1-3-5-9)7-18-15(10)14-12(13)8-19-16(14)20/h1-7,18H,8H2,(H,19,20)
Standard InChI Key: IWKDQQIVXBSVBE-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 23 0 0 0 0 0 0 0 0999 V2000
-1.7567 -0.0325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0421 0.3797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3301 -0.0320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3301 -0.8573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0403 -1.2690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7567 -0.8610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2814 0.5175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8704 1.1840 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0523 1.2690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5446 0.2234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5446 -1.1170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0315 -0.4467 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0759 0.3045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6578 0.8861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4498 0.6731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6628 -0.1216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0851 -0.7015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2898 -0.4933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7574 1.0179 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.0371 -2.0941 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
3 7 1 0
2 8 1 0
8 9 1 0
9 7 2 0
1 10 1 0
6 11 1 0
11 12 1 0
12 10 1 0
13 7 1 0
14 13 2 0
15 14 1 0
16 15 2 0
17 16 1 0
13 18 1 0
18 17 2 0
10 19 2 0
5 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 282.73 | Molecular Weight (Monoisotopic): 282.0560 | AlogP: 3.73 | #Rotatable Bonds: 1 |
Polar Surface Area: 44.89 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.14 | CX Basic pKa: ┄ | CX LogP: 3.15 | CX LogD: 3.15 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.70 | Np Likeness Score: 0.08 |
References
1. Qin Z, Qin L, Feng X, Li Z, Bian J.. (2021) Development of Cdc2-like Kinase 2 Inhibitors: Achievements and Future Directions., 64 (18.0): [PMID:34519506] [10.1021/acs.jmedchem.1c00985] |